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T-cell transcriptome analysis points up a thymic disorder in id-
iopathic nephrotic syndrome.
Background. Idiopathic nephrotic syndrome is a proteinuric
disease secondary to the release of a nonidentified circulating
glomerular permeability factor by T cells. Because specificities
of T-cell activation in idiopathic nephrotic syndrome remain
unknown, we evaluated transcriptional activation of T cells in
nephrotic patients during proteinuria.
Methods. Transcriptomes of CD2+ cells were analyzed by
serial analyis of gene expression (SAGE) in a nephrotic child
during proteinuria relapse and after remission, away from
any immunosuppressive treatment. Expression of specific tran-
scripts overexpressed during proteinuria relapse was compared
by reverse transcription-polymerase chain reaction (RT-PCR)
in CD2+ cells from 11 nephrotic patients during relapse and re-
mission and 11 nonnephrotic patients during infection and after
recovery.
Results. Differential analysis of CD2+ cell transcriptome
identified >200 mRNA tags overexpressed during proteinuria
relapse, including many T-cell markers. RT-PCR analysis of ex-
pression of specific transcripts indicated that (1) under remis-
sion conditions, nephrotic children displayed induction of four
transcripts, including IKBKB, and repression of NFKBIA as
compared to nonnephrotic children after recovery, and (2) pro-
teinuria relapse was associated with induction of L-selectin and
T-lymphocyte maturation–associated protein, two markers of
T-cell differentiation and recent emigrant/naive T cells.
Conclusion. Results indicate that circulating T cells from re-
lapsing nephrotic patients include a significant population of
low-mature cells while those from nephrotic patients in re-
mission are characterized by constitutive activation of nuclear
factor-jB (NF-jB), altogether suggesting a thymic dysregula-
tion of apoptosis in nephrotic patients.
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Idiopathic nephrotic syndrome, the most frequent re-
nal disease in childhood, is characterized by massive pro-
teinuria (>50 mg/kg/day) leading to hypoalbuminemia
(<30 g/L). Histopathologic changes are restricted to ef-
facement of the podocytic foot processes without signifi-
cant glomerular deposit or inflammatory lesion. In most
cases, proteinuria and foot process effacement are com-
pletely reversible under steroids, without sequellae. Clin-
ical and experimental data support that this renal disease
is primarily a T-cell disease leading to the release of a
glomerular permeability factor in the blood circulation:
(1) idiopathic nephrotic syndrome is sensitive to steroid
therapy in >90% of the patients, (2) T-cell immunosup-
pressive drugs (mainly cyclophosphamide and antical-
cineurin agents) as well as measles are also able to induce
remission of proteinuria, (3) lymphoma and thymoma
are significantly associated with idiopathic nephrotic syn-
drome in children and adults, (4) massive but transient
proteinuria is observed in neonates from nephrotic moth-
ers, and proteinuria resumes soon after renal transplan-
tation in patients with a steroid-resistant form who
progressed toward end-stage renal failure, (5) conversely,
recipients of a kidney from a patient deceased during a
relapse of idiopathic nephrotic syndrome rapidly recover
from proteinuria, and (6) plasma and serum as well as
T-cell hybridoma supernatant from nephrotic patients in-
duce proteinuria in rats [1].
T-cell dysfunction during proteinuria relapse in
patients with idiopathic nephrotic syndrome is not prop-
erly characterized yet, as data from the past decade
are rather misleading. Analysis of T-cell subpopulations
revealed no reproducible difference in CD3+, CD4+,
and CD8+ cells distribution between patients in re-
lapse and patients in remission or healthy children [2, 3].
Th1/Th2 balance studies provided controversial results.
The profile of serum cytokines indicated a Th1 activation
pattern during relapse [3, 4], whereas mRNA cytokines
profile supported a Th2 pattern [5]. In addition, analysis
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of intracellular cytokines profile during relapse con-
cluded to a Th2 activation pattern in CD4+ cells [6], a
Th1 pattern in CD3+ cells [7], and no significant shift
of the Th1/Th2 balance in CD4+ cells [8]. Peripheral
blood mononuclear cells (PBMCs) from patients with id-
iopathic nephrotic syndrome express a truncated c-maf
inducing protein (Tc-mip) which, when expressed in T-
cell Jurkat, induces a Th2 commitment [9]. Conversely,
increased interleukin (IL)-12 release by monocytes from
nephrotic patients supports Th1 activation [10]. Thus, the
specificities of T-cell activation remain to be described in
idiopathic nephrotic syndrome.
Identification of the circulating glomerular permeabil-
ity factor in idiopathic nephrotic syndrome has failed also
despite numerous attempts over the past three decades.
Purification of the factor was first based on plasma frac-
tionation and different biologic assays: subcutaneous
diffusion of Evans blue [11], heparin desorption [12],
induction of proteinuria in rat or rabbit with human
plasma [13], and decreased synthesis of glomerular hep-
aran sulfate [14]. Additional works included studies of
hybridoma supernatants [15], fractionation of plasma elu-
ates from protein A [16], or anti-IgG affinity columns [17],
as well as genomic analysis of PBMCs [18]. The circulat-
ing glomerular permeability factor was not characterized
either in recurrent focal and segmental glomerulosclero-
sis on renal transplant [13, 16, 17, 19, 20].
The present study was designed (1) to characterize the
changes in T-cell transcripts profile during proteinuria in
children with idiopathic nephrotic syndrome, (2) to com-
pare the mRNA activation profile of T cells in nephrotic
and nonnephrotic children, and (3) to search, among tran-
scripts induced during proteinuria, for candidates as
circulating glomerular permeability factor. Changes in
transcriptome were analyzed using serial analysis of gene
expression (SAGE) in T cells sampled in a same pa-
tient during proteinuria and remission. Specific tran-
scripts expression was compared by quantitative reverse
transcription-polymerase chain reaction (RT-PCR) be-
tween T cells from nephrotic patients during proteinuria
relapse and remission and nonnephrotic patients during
infection and after recovery.
METHODS
Patients
SAGE libraries were prepared from T cells from a boy
with a history of steroid-sensitive idiopathic nephrotic
syndrome, defined by complete remission of proteinuria
within 4 weeks of oral prednisone (2 mg/kg/day). A “re-
lapse” library was prepared from blood sampled when
the boy was 10.2 years, during a proteinuria relapse (pro-
teinuria 3.05 g/L and serum albumin 16.5 g/L) occurring
21.3 months after stopping prednisone. Blood was sam-
pled before the initiation of steroid therapy, and in ab-
sence of any other medication. A “remission” library was
prepared from blood sampled during remission (unde-
tectable proteinuria and serum albumin 44.6 g/L) 16.5
months after prednisone withdrawal, no other medica-
tion being given to the patient.
T-cell expression of a selection of candidate genes was
then evaluated by real-time RT-PCR in a group of 11 pa-
tients (four boys and seven girls) with steroid-sensitive id-
iopathic nephrotic syndrome, which includes the patient
selected for transcriptome analysis (patient 3). Patients
were aged 6.4 ± 3.0 and 7.3 ± 3.2 years at the time of
the two blood samplings, respectively. Blood was sam-
pled at the time of relapse (proteinuria 8.8 ± 7.6 g/L
and serum albumin 13.9 ± 4.9 g/L) at least 4 weeks af-
ter withdrawal of any immunosuppressive drug and be-
fore initation of immunosuppressive drugs, and at the
time of remission (undetectable proteinuria) at least 2
weeks following prednisone withdrawal. Patients did not
receive any other medication since at least 4 weeks at
the time of both blood samplings. These samples will be
referred to as “nephrotic relapse” and “nephrotic remis-
sion,” respectively. In order to determine the specificity
of T-cell activation in proteinuric disease, we used a con-
trol group of patients with T-cell activation in response
to infectious disease but without history of proteinuria.
Eleven patients matched in age and gender (five boys
and six girls, aged 7.6 ± 2.8 years) with high fever and
severe infectious diseases were selected. Four had a virus
infection (patients 27, 77, 100, and 110), five had acute
malaria (patients 103, 104, 105, 106, and 108), and two had
acute pyelonephritis (patients 17 and 121). Patients were
successively sampled at the time of fever (“nonnephrotic-
infection”) and at least 1 week following clinical recovery
(“nonnephrotic-recovery”). This work was approved by
the local ethic committee, and written consents of patients
and/or parents were obtained for each couple of samples.
T-cell isolation
Blood was collected from a forearm vein into
potassium ethylenediaminetetraacetic acid (EDTA)-
containing tubes and kept at room temperature until
fractionation (performed within 6 hours after sampling).
T cells were isolated using anti-CD2 magnetic beads
(Dynal, Oslo, Norway) according to the manufacturer’s
protocol. CD2 is a specific marker of the whole T-cell lin-
eage. T cells adsorbed to anti-CD2 beads were directly
lysed using the Dynal lysis solution, and the lysates were
frozen at −80◦C until use.
SAGE libraries
SAGE [21] consists in characterizing each cDNA ob-
tained by retrotranscription of tissue mRNAs by a short
(10 bp) informative nucleotide sequence, or tag. Several
transcript-specific tags are concatenated into long DNA
2170 Mansour et al: T-cell gene expression in nephrotic syndrome
Table 1. Number of tags differentially represented in relapse (Rel) and remission (Rem) libraries
cDNAs
Known function Unknown function Multiple matches No reliable match No match Total
Rel > Rem 179 (79%) 8 (3%) 12 (5%) 24 (11%) 5 (2%) 228
Rem >Rel 13 (10%) 3 (2%) 2 (1%) 63 (48%) 51 (39%) 132
Total 192 (53%) 11 (3%) 14 (4%) 87 (24%) 56 (16%) 360
EST, expressed sequence tag. Number of tags differentially represented in relapse and remission libraries in the different classes of identification through GenBank
match. Tags matching to a cDNA were subdivised into two classes on the basis of the presence or absence of a functional characterization of the protein encoded by
the cDNA. Multiple matches: tags with >two reliable identifications in GenBank; No reliable match: tag matching to cDNA(s) or EST(s) without poly(A) signal or
poly(A) tail; No match is a tag without any matching sequence in GenBank.
molecules which are cloned and sequenced. Computer-
assisted analysis of the sequences permits to extract, clas-
sify, and count the different tags, and data base queries
allow identification. The method is quantitative as the
relative abundance of the different tags in the library
reflects the abundance of the cognate transcripts in the
biologic sample. SAGE libraries were generated using
the adaptation for downsized extracts (SADE) [22]. The
main modifications of this protocol consists in the use of
oligo(dT)25-coated magnetic beads (Dynabeads mRNA
Direct Kit) (Dynal) to purify poly(A) RNAs from T-cell
lysates, and the use of Sau3AI as the anchoring enzyme.
Tags extraction and counting, and comparison of the
two libraries were performed using SAGE2000 software
[21]. Tags corresponding to linker sequences were dis-
carded, and those originating from duplicate ditags were
counted only once.
Identification of tags was first performed through
matching to UniGene clusters using SAGEmap
(www.ncbi.nlm.nih.gov/SAGE) and carried out up to
June 2004. Next, the reliability of the UniGene identifi-
cation was validated by confirming the correct location
and orientation of the tag in relation to the 3′-most
Sau3AI site, as well as the presence of a polyadenylation
signal and/or poly(A) tail.
Real-time RT-PCR
RNAs were extracted from T-cell lysates using an adap-
tation [23] of the method of Chomczynski and Sacchi,
and reverse transcribed using the First-Strand cDNA
Synthesis Kit for RT-PCR (Roche Diagnostics, Meylan,
France), according to the manufacturer’s protocol. Real-
time PCR was performed on a LightCycler (Roche Di-
agnostics) with the LightCycler FastStart DNA Master
SYBR Green 1 Kit (Roche Diagnostics) according to the
manufacturer’s protocol, except that the final reaction
volume was reduced to 8 lL. Primers (sequences avail-
able upon request) were designed using oligo 4.04 (Na-
tional Biosciences, Plymouth, MA, USA). Samples were
submitted to 30 to 40 cycles of three temperature steps
(95◦C for 10 seconds; 60 to 62◦C for 10 seconds; and 72◦C
for 25 seconds) followed by a fusion curve. In each ex-
periment, a standardization curve was made using serial
dilutions (1 to 1/500) of a cDNA stock solution made of
a mixture of cDNAs from nephrotic and nonnephrotic
samples. The amount of PCR product was calculated as
percent of the standard cDNA. Expression of the differ-
ent genes in each sample was expressed relatively to that
of ribosomal protein L28 which remained constant. Re-
sults are presented either as mean values ± SE in the
four groups of samples (nephrotic remission, nephrotic
relapse, nonnephrotic recovery, and nonnephrotic infec-
tion), or as individual ratios between activated and rest-
ing conditions in nephrotic (nephrotic relapse/nephrotic
remission) and nonnephrotic patients (nonnephrotic in-
fection/nonnephrotic recovered).
Statistics
Significant differences in tag abundance between the
two libraries were assessed by Monte-Carlo analysis [24],
P < 0.05 being considered as significant. This method,
which is based on large number (100, 000) simulations
to determine the probability of obtaining the observed
difference in tag abundance, was chosen because it is
part of the SAGE2000 software used to analyze SAGE
data. In RT-PCR experiments, values statistically dif-
ferent between groups were assessed either by paired t
test (nephrotic relapse vs. nephrotic remission and non-
nephrotic recovered vs. nonnephrotic infection) or by
variance analysis (nephrotic remission vs. nonnephrotic
recovered), P < 0.05 being considered as significant.
RESULTS
T-cell transcriptome in a patient with proteinuria relapse
and remission
A total of 24,665 and 24,336 tags were sequenced
in the remission and relapse libraries respectively
(see complete list in Supplemental Table 1 http://www.
blackwellpublishing.com/products/journals/suppmat/kid/
kid322/kid322sm.htm). The fusion of the two libraries
generated 23,863 different tags. This T-cell transcriptome
is characterized by the following: (1) 38% of all tags
(79% of the molecular species) were counted only
once; (2) 170 tags (7% of the molecular species) were
counted ≥25 and their cumulative abundance accounted
for 27% of all tags; (3) the most abundant tag, which
corresponded to translation elongation factor 1 alpha 1,
represented >1% of all tags; and (4) 70 of the 170 most
represented tags encoded ribosomal proteins.
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A total of 360 tags were differentially expressed
(P < 0.05) in the two libraries (http://www.
blackwellpublishing.com/products/journals/suppmat/kid/
kid322/kid322sm.htm Supplemental Table 2), including
228 tags overrepresented in the relapse library. Among
the differentially represented tags, 56% were reliably
identified as single cDNAs whereas 16% (56 tags) did
not match any GenBank sequence (Table 1).
Supplemental Table 3 http://www. blackwellpublishing.
com/products / journals/suppmat/kid/kid322/kid322sm.
htm lists the 179 tags over represented in the relapse li-
brary which were identified in GenBank as single cDNAs
with known functions. This list includes 21 transcripts
coding for T-cell surface markers with distinct functions:
class I major histocompatibility complex (MHC), sub-
units of the T-recognition complex (two variants of the b
subunit TRBC1, CD3D associated with the d subunit, and
the c subunit TRG@), the early activation-dependent
surface antigen CD97; other markers of T cells (SELL,
MAL, and KLRK1), components of the immunologic
synapse (CD6, CD48, and LAT), and genes involved
in T-cell growth balance (LRRN4 and IFITM1) and
survival (SELS, IL7R, TNFRSF7, and LTB). The largest
functional class of transcripts over expressed during
relapse encodes proteins involved in protein synthe-
sis (52 ribosomal proteins and 7 translation factors),
processing (7 chaperonins) and degradation (7 ubiqui-
tination proteins), demonstrating a massive induction
of protein metabolism during relapse. Other impor-
tant functional classes include actin subunits and
actin-interacting proteins (11 transcripts) and proteins
involved in energy supply (19 transcripts) and signal
transduction (24 transcripts). Genes encoding potent
transcription factors (JUNB, JUND, FYN, ENO1, and
TCF7, which is specific for T cells) as well as two thymic
hormones inducing T-cell differentiation (PTMA and
TMSB10) were overrepresented during relapse (Fig. 1).
Comparison of T-cell activation in nephrotic and
control patients
To validate SAGE data and to characterize a puta-
tive specificity of T-cell activation in nephrotic relapse
as compared to nonproteinuric infection, T-cell expres-
sion of a selection of transcripts was compared between
nephrotic patients (during proteinuria relapse and remis-
sion) and nonnephrotic patients (during infection and af-
ter recovery). The criteria for transcripts selection were
the following: (1) transcripts with a relapse/remission
abundance ratio ≥5, (2) transcripts encoding proteins
with a signal peptide sequence or a transmembrane do-
main, as they might be released in the blood by shed-
ding and thereby putatively act as circulating permeabil-
ity factor (putative transmembrane domains were deter-
mined using SMART (http://smart.embl-heidelberg.de/)
and PSORT II (http://psort.nibb.ac.jp/form2.html) soft-
wares), and (3) transcripts from most functional classes
of genes, as defined in Figure 1. Thus, the 39 selected
genes included (1) all genes coding for surface mark-
ers, except MHC genes which displayed a high consti-
tutive expression in the remission library, (2) genes of
unknown function with a putative transmembrane do-
main (FLJ21438 and C20orf52), (3) genes coding for
secreted proteins (TGFB1 and GPX4), and (4) genes
coding for intracellular proteins involved in nucleic acid
metabolism (ADAR), protein synthesis (EIF4G2, HN-
RPC, and CIRBP), protein processing (TAPBP, RPN2,
CCT7, SSR4, and PSMA6), cytoskeleton-related pro-
teins (COTL1 and CORO1A), energy metabolism (ND-
UFA3 and NDUFB8), and signalization (ARL10A and
IKBKB). Although their tag abundance was not altered
in the relapse SAGE library, we also included NFKB1
and NFKBIA which, along with IKBKB, control a major
regulatory pathway in T cells.
Table 2 summarizes both mean mRNA expression
(normalized to expression of RPL28 transcripts) in
the four groups of samples, and individual changes in
mRNA level during proteinuria relapse (nephrotic re-
lapse/nephrotic remission) and infection (nonnephrotic
infection/nonnephrotic recovery) in nephrotic and non-
nephrotic patients, respectively, and Figure 2 shows
paired data for some transcripts. Note that in non-
nephrotic patients, the profile of activation of gene ex-
pression during infection is independent of the disease
(viral infection, malaria, or pyelonephritis). In nephrotic
patients, only five genes (SELL, MAL, ADAR, EIF4G2,
and IKBKB) were statistically significantly induced
during proteinuria relapse, whereas 24/39 genes were
significantly induced during infection in nonnephrotic
patients. Genes induced during infection in nonnephrotic
patients include FLJ21438 (induced in 9/11 patients),
which encodes a hypothetical protein with a RasGAP
domain likely involved in intracellular signalization. In-
terestingly, MAL was the only gene specifically induced
in nephrotic patients but not in controls (Fig. 2). Under
resting conditions (remission or recovery), four genes
(CD3D, FLJ21438, COTL1, and IKBKB) were over-
expressed in nephrotic as compared to nonnephrotic
patients (nephrotic remission vs. nonnephrotic recov-
ery), whereas six genes were repressed (SELL, KLRK1,
TGFB1, ARL10A, CCT7, and NFKBIA).
Analysis of changes in gene expression during T-cell
activation (proteinuria relapse or infection) at the indi-
vidual level indicates that (1) there was an heterogeneity
in gene expression in both nephrotic and nonnephrotic
patients, possibly due in part to the different stages of
disease evolution (duration of proteinuria or of infec-
tion) at the time of blood sampling; (2) in patient 3 whose
T cell served to generate the SAGE libraries, RT-PCR
confirmed the SAGE analysis except for LTB (SAGE
relapse/remission 12/1 and RT-PCR relapse/remission
0.9) and for NFKB1 for which the 15.8-fold induction
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Miscellaneous
Cell surface markers
Cytoskeleton
Signal transduction
Protein synthesis, processing,
and metabolism
Energy and oxidative metabolism
Nucleic acid metabolism
Fig. 1. Functional classes of genes for tags
represented at statistically higher level in the
relapse than in the remission library. The 179
functionally identified tags overrepresented
in the relapse library were clustered into seven
functional subgroups. List of genes in each
cluster is available in supplemental Table 3.
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Fig. 2. Quantitative reverse transcription-
polymerase chain reaction (RT-PCR) anal-
ysis of mRNAs expression in T cells from
nephrotic patients during proteinuria relapse
(rel) and after remission (rem) and non-
nephrotic patients during infection (inf) and
after recovery (rec). RT-PCR data are ex-
pressed relative to ribosomal protein L28
mRNA. SELL, L-selectin (lymphocyte adhe-
sion molecule 1) (CD62L); MAL, mal, T-cell
differentiation protein; IKBKB, inhibitor of
kappa light polypeptide gene enhancer in B-
cells, kinase beta; NFKBIA, nuclear factor
of kappa light polypeptide gene enhancer in
B-cell inhibitor, alpha. Lines join values ob-
tained in the same patients under the two
pathophysiologic conditions.
observed by RT-PCR could not be revealed by SAGE;
(3) gene induction was much less frequent in nephrotic
patients than in nonnephrotic (175 vs. 249 green boxes
in Table 2), whereas the opposite holds for gene repres-
sion (66 vs. 28 red boxes); and (4) a single gene (SELL
or CD62L) was induced in all nephrotic patients.
L-Selectin as a putative glomerular permeability factor
L-Selectin, the product of CD62L, was considered as
a potential glomerular permeability factor because (1)
it was induced in all relapsing nephrotic patients, (2)
it is a transmembrane protein with an extracellular do-
main which can be cleaved and released from the cell
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TM CCP CCP EGF C-lectin
Cleavage site by ADAM17 Putative cleavage site
20 kD
Control Nephrotic
B
C
A
Fig. 3. Search for the presence of L-selectin
in plasma and kidney of control and
nephrotic patients. (A) Schematic repre-
sentation of L-selectin with its transmem-
brane domain (TM), complement control
protein domains (CCP), epidermal growth
factor domain (EGF) and C-lectin domain,
as well as its known and putative sites
of cleavage by proteases. (B) Plasma from
three control and three nephrotic patients in
relapse were submitted to sodium dode-
cyl sulfate-polyacrylamide gel elctrophore-
sis (SDS-PAGE) (10% polyacrylamide gels)
under denaturating conditions and to im-
munoblotting using an anti-L-selectin anti-
body directed against the C-lectin domain
of L-selectin (Santa Cruz Biotechnologies,
Santa Cruz, CA, USA). The ≈19 kD pro-
tein visualized by chemiluminescence of a
secondary antibody corresponds to the C-
lectin domain of L-selectin. (C) Unprocessed
fragments of kidney biopsies from a non-
nephrotic patient (control) and a nephrotic
patient in relapse were used for L-selectin im-
munocytochemistry using the same antibody
as above. Antigen-antibody complexes were
revealed with a Cy3-conjugated goat antirab-
bit IgG (Jackson Immuno Research Labora-
tories, West Grove, PA, USA) and sections
were examined with a fluorescence micro-
scope. L-Selectin staining was absent in both
control and nephrotic glomerulus.
surface through either ADAM17-dependent or indepen-
dent pathways [25], and (3) in high endothelial venules,
L-selectin interacts with podocalyxin, a protein also ex-
pressed in podocytes where it is essential for the integrity
of slit diaphragms structure. The extracellular domain of
L-selectin consists of an extracellular C-lectin domain,
responsible for the interaction with podocalyxin, linked
in tandem to an epidermal growth factor (EGF) domain
and several short consensus repeats homologue to com-
plement binding proteins (Fig. 3A). In silico analysis of L-
selectin sequence revealed that the short domain linking
the C-lectin and the EGF domains contains a consensus
sequence for protease similar to that linking the trans-
membrane and the extracellular domains. In addition, we
demonstrated that the C-lectin domain can be released in
the blood since, using an anti-C-lectin domain antibody,
we identified in the plasma a protein of 19 kD, consistent
with the size of the C-lectin domain (Fig. 3B). However,
the C-lectin domain was less abundant in the plasma dur-
ing proteinuria than in remission (Fig. 3B), likely as the
result of decreased plasma protein content. In addition,
immunohistochemistry on human renal biopsies failed
to demonstrate the presence of the C-lectin domain on
podocytes of either nonnephrotic or nephrotic patients
during relapse (Fig. 3C), whereas the antibody staining
was positive on liver sections.
DISCUSSION
Transcriptional activation of T cells was investigated in
patients with steroid-sensitive idiopathic nephrotic syn-
drome, in absence of any steroid or immunosuppres-
sive therapy. The study was carried out on circulating
CD2+ cells because CD2 is a specific marker of the
whole T-cell lineage expressed from the earliest stages
of T commitment in the thymus to mature circulating T
cells. Differential analysis of CD2+ cell transcriptomes
in a nephrotic patient identified 228 mRNA tags, in-
cluding a large number of markers of T-cell activation,
overrepresented during proteinuria relapse. It cannot
be inferred, however, whether overexpression of these
genes is a cause or a consequence of proteinuria. RT-PCR
analysis of 39 transcripts in nephrotic and nonnephrotic
patients revealed that (1) >20% of these transcripts
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displayed differential expression between nephrotic and
nonnephrotic patients under resting conditions, (2) only
MAL was activated in relapsing nephrotic patients but
not during infection in nonnephrotic patients, (3) tran-
scriptional activation was lesser in relapsing nephrotic pa-
tients than in nonnephrotic ones during infection, and (4)
among genes encoding putatively secreted proteins, only
CD62L was induced in all relapsing nephrotic patients.
T-cell activation in nephrotic syndrome
Many transcripts over represented in the “relapse” li-
brary encode T-cell surface markers, transcription factors
involved in T-cell survival, and actin and cytoskeleton-
related proteins closely involved in T-cell activation [26].
This validates the procedure for T-cell purification; in
particular it demonstrates that the use of CD2 beads did
not induce nonselective activation of lymphocytes.
Among transcripts over expressed during proteinuria
relapse, SELL and MAL deserve special attention be-
cause SELL was the only transcript induced in all relaps-
ing patients and MAL was overexpressed in relapsing
patients but not during infection in nonnephrotic patients.
CD62L, which was previously reported as being induced
during proteinuria in nephrotic patients [18], is an early
marker of T-cell commitment in bone marrow progeni-
tors [27] and is involved in thymic homing [28]. CD62L
is also expressed in circulating recent thymic emigrant
and naive T cells (in which it plays a major role in lymph
nodes homing), but its expression is markedly reduced
in mature T cells [29]. MAL (T-lymphocyte maturation–
associated protein) is a proteolipid expressed at T-cell
surface which is a marker of late thymic T-cell differenti-
ation [30]. Accordingly, it is strongly expressed in thymus
cortex, but it is also found in a population of peripheral
CD4+ T cells [31]. Thus, the overexpression of SELL and
MAL in peripheral CD2+ cells reveals a population of
low-mature circulating T cells (recent emigrant and naive
T cells) in nephrotic patients. This conclusion is also sup-
ported by the over expression in relapsing patients of Tc-
mip, a signaling factor much more abundant in thymus
than in circulating PBMCs [9].
Differences in T-cell expression profile in nephrotic and
nonnephrotic individuals in remission
The most striking findings were the changes in ex-
pression level under basal condition (remission or re-
covery) in nephrotic versus nonnephrotic patients of
several genes involved in the control of apoptosis. Re-
pression of NFKBIA (IKBa) in nephrotic remission
versus nonnephrotic recovery patients, which largely ac-
counts for the repression previously reported between re-
lapsing patients and non nephrotic controls [32], joined
with the induction of IKBKB, which specifically phos-
phorylates and inactivates IKBa, leads to an hyperacti-
vation of nuclear factor-jB (NF-jB) profile in nephrotic
patients in remission. In T-cell lineage, NF-jB plays a
central role in the control of cytokine expression, T cell
proliferation after T-cell receptor engagement, as well as
quality control of thymocytes through the regulation of
apoptosis [33]. As a matter of fact, NF-jB displays dual
effects in the control of apoptosis. It is required for
aCD3-mediated apoptosis of double positive thymo-
cytes [34] but it is also essential for protecting T cells
against tumor necrosis factor (TNF)-induced apoptosis
[35]. Changes in transcript expression as well as clinical
observations indicate that both pro- and antiapoptotic
pathways are involved in idiopathic nephrotic syndrome.
Activation of antiapoptotic pathway is supported by the
repression of ARL10A which belongs to the proapop-
totic adenosine diphosphate (ADP)-ribosylation factors
[36], and by the beneficial effect of thymic proapop-
totic factors on the disease. Indeed, first, prednisone and
cyclophosphamide induce marked proapoptotic actions
on thymocytes [37, 38], which may lead to complete
loss of thymic cortex [39] and prolonged remissions in
nephrotic patients [40, 41]. Second, similarly, measles lead
to thymic apoptosis [42] and induce permanent remis-
sion [43]. Third, conversely, cyclosporine which decreases
apoptosis in the thymic corticomedullary area [44], the
site of negative selection, rarely induces sustained re-
mission in nephrotic patients after treatment withdrawal
[45]. Finally, decrease activity of idiopathic nephrosis ob-
served with aging [46] is temporally associated with thy-
mus involution [47]. Conversely, activation of apoptosis
is supported by the repression of the antiapoptotic gene
TGFB1 [48] and by the close association between an-
tithymoglobulin therapy which induces peripheral T-cell
apoptosis [49] and early relapse of nephrotic syndrome
in transplanted patients [50]. Thus, the constitutive acti-
vation of NF-jB pathway in peripheral CD2+ cells may
reveal a dysregulation of thymus and peripheral T-cell
apoptosis in nephrotic patients during remission. This
thymic defect, along with the over expression of CD3D,
which is associated with thymocyte differentiation [51,
52], may be responsible for the presence of a low-mature
circulating T-cell population in relapsing nephrotic pa-
tients. CCT7, which is repressed in nephrotic remission
vs. nonnephrotic recovery patients, is a T-complex protein
1 subunit involved in Fas-induced apoptosis of Jurkat T
cells [53] which belongs to the SSNS1 (steroid sensitive
nephrotic syndrome 1) locus [54].
Glomerular permeability factor
The identification of the glomerular permeability fac-
tor in idiopathic nephrotic syndrome has remained unan-
swered despite an outstanding number of studies. The
C-lectin domain of L-selectin appeared as a good can-
didate because (1) expression of L-selectin gene was in-
duced during proteinuria in all nephrotic patients (Table
2) and the C-lectin domain of L-selectin was released in
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the plasma (Fig. 3B); (2) apoptosis, which is altered in
T cells from nephrotic patients, induces L-selectin shed-
ding from T-cell surface [55]; (3) the C-lectin domain is
responsible for the specific interaction of L-selectin with
sulfated sialyl Lewis(x) carbohydrate of podocalyxin in
high endothelial venules, permitting lymphocytes hom-
ing into lymph nodes [56]; and (4) podocalyxin is an
important protein for the integrity of the glomerular fil-
ter. Indeed, uncoupling of podocalyxin from the actin
skeleton leads to the loss of glomerular foot processes in
three different experimental models of heavy proteinuria
and nephrotic syndrome [57], and transgenic mice lacking
podocalyxin exhibit profound defects in kidney develop-
ment and die within 24 hours after birth [58]. However,
the presence of the C-lectin domain in control plasma and
the absence of detectable C-lectin domain of L-selectin
on podocytes from nephrotic patients makes unlikely its
role as the glomerular permeability factor unless its in-
teraction with glomerular podocalyxin is labile, like the
interaction of L-selectin with high endothelial venules. In
particular, it is possible that the podocalyxin/C-lectin do-
main interaction is no longer possible once it has induced
effacement of the podocytic foot processes.
Alternatively, we may have missed the permeabil-
ity factor in our screening of T-cell transcriptome. It is
worth recalling that although we studied the largest T-
cell molecular population ever analyzed in idiopathic
nephrotic syndrome (>20,000 different mRNA tags),
SAGE is not an exhaustive method. Indeed, first, ≈5%
cDNAs lack the anchoring enzyme (Sau3AI) site and
therefore were excluded from SAGE analysis. Sec-
ond, transcripts displaying AT-rich elements in their
3′untranslated region (UTR), a common feature for lym-
phokines and cytokines [59], are submitted to an intense
degradation which may compromise their full recollec-
tion. Third, analysis of 25,000 tags provides a 95% con-
fidence level for detecting transcripts expressed at ≥35
copies per cell [60], therefore excluding transcripts with
low expression level as those coding for a majority of
lymphokines and cytokines [59]. In addition, unidenti-
fied tags were obviously excluded from the screening of
putative secreted proteins.
In view of the accumulation over the past three decades
of fruitless attempts to identify a circulating glomerular
factor of T-cell origin in nephrotic syndrome, one might
question whether circulating T lymphocytes are the actual
source for this factor.
CONCLUSION
Circulating T cells from relapsing nephrotic patients
are likely including a significant population of low-mature
cells closely related to thymocytes or naive T cells freshly
coming from the thymus. Constitutive activation of NF-
jB, along with other pro- and antiapoptotic markers, dur-
ing remission might represent a defect in thymocyte apop-
tosis and selection. Present results provide a molecular
basis for the “special role for the thymus” proposed by
Shalhoub [43] in the primary pathogenesis of idiopathic
nephrotic syndrome some 30 years ago.
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